JP2014508298A5 - - Google Patents

Download PDF

Info

Publication number
JP2014508298A5
JP2014508298A5 JP2013555939A JP2013555939A JP2014508298A5 JP 2014508298 A5 JP2014508298 A5 JP 2014508298A5 JP 2013555939 A JP2013555939 A JP 2013555939A JP 2013555939 A JP2013555939 A JP 2013555939A JP 2014508298 A5 JP2014508298 A5 JP 2014508298A5
Authority
JP
Japan
Prior art keywords
biomarkers
expression
pancreatic cancer
measuring
biomarkers listed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013555939A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014508298A (ja
JP6161542B2 (ja
Filing date
Publication date
Priority claimed from GBGB1103726.4A external-priority patent/GB201103726D0/en
Application filed filed Critical
Publication of JP2014508298A publication Critical patent/JP2014508298A/ja
Publication of JP2014508298A5 publication Critical patent/JP2014508298A5/ja
Application granted granted Critical
Publication of JP6161542B2 publication Critical patent/JP6161542B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013555939A 2011-03-04 2012-03-05 方法、アレイ及びその使用 Expired - Fee Related JP6161542B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1103726.4A GB201103726D0 (en) 2011-03-04 2011-03-04 Method, array and use thereof
GB1103726.4 2011-03-04
PCT/GB2012/050483 WO2012120288A2 (en) 2011-03-04 2012-03-05 Method, array and use thereof

Publications (3)

Publication Number Publication Date
JP2014508298A JP2014508298A (ja) 2014-04-03
JP2014508298A5 true JP2014508298A5 (enExample) 2015-04-16
JP6161542B2 JP6161542B2 (ja) 2017-07-12

Family

ID=43923218

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013555939A Expired - Fee Related JP6161542B2 (ja) 2011-03-04 2012-03-05 方法、アレイ及びその使用

Country Status (9)

Country Link
US (4) US9863960B2 (enExample)
EP (1) EP2681563A2 (enExample)
JP (1) JP6161542B2 (enExample)
KR (2) KR102014890B1 (enExample)
CN (2) CN107064518A (enExample)
CA (1) CA2828338A1 (enExample)
GB (1) GB201103726D0 (enExample)
MX (1) MX363201B (enExample)
WO (1) WO2012120288A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442919T3 (es) 2007-03-27 2014-02-14 Immunovia Ab Firma/marcadores de proteínas para la detección de adenocarcinoma
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
KR101658164B1 (ko) * 2014-04-28 2016-09-21 서강대학교산학협력단 브롬 동위원소 신호를 이용한 자유 라디칼-개시 펩타이드 시퀀싱 질량분석
KR20150129932A (ko) * 2014-05-12 2015-11-23 연세대학교 산학협력단 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트
CN105572276B (zh) * 2014-11-07 2018-12-18 上海市第六人民医院 胰腺癌诊断标记物组合、应用及其测定方法
CN104698170A (zh) * 2015-03-17 2015-06-10 任传利 Il-11作为生物标记物在胰腺癌诊断和预后评价的方法
EP3073268A1 (en) 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
JP5852759B1 (ja) * 2015-04-01 2016-02-03 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
GB201516801D0 (en) 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof
JP6392201B2 (ja) * 2015-12-04 2018-09-19 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
JP5970123B1 (ja) * 2015-12-04 2016-08-17 株式会社キュービクス 遺伝子発現解析による膵臓癌の検出
US20190048068A1 (en) * 2016-02-05 2019-02-14 Dana Genetic A/S Method for diagnosing and treating cancer using antibodies that bind to c1 inactivator, c reactive protein and/or complement component c4
GB201608192D0 (en) 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
DE202017007363U1 (de) 2016-12-16 2021-02-16 The Brigham And Women's Hospital, Inc. Zusammensetzung von Partikeln mit Eisenoxidkernen
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
GB201701572D0 (en) 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
KR102536314B1 (ko) * 2018-05-23 2023-05-25 주식회사 휴벳바이오 질환의 진단용 조성물
WO2020096631A2 (en) 2018-11-07 2020-05-14 Seer, Inc. Compositions, methods and systems for protein corona analysis and uses thereof
CA3127569A1 (en) * 2019-02-18 2020-08-27 The University Of Liverpool Method of diagnosis
GB2599796A (en) 2019-03-26 2022-04-13 Seer Inc Compositions, methods and systems for protein corona analysis from biofluids and uses thereof
EP4010456A4 (en) 2019-08-05 2023-09-13 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis
GB202010970D0 (en) * 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CA3190719A1 (en) 2020-08-25 2022-03-03 Daniel Hornburg Compositions and methods for assaying proteins and nucleic acids
CN113655144A (zh) * 2021-08-09 2021-11-16 大连医科大学附属第一医院 一种基于丙酮酸激酶和α-2-HS-糖蛋白的早期预警重症急性胰腺炎的预测模型

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3169789D1 (en) 1980-05-02 1985-05-15 Edward P Davis Leg aid device
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
JP4194080B2 (ja) 2003-02-19 2008-12-10 茂 森村 膵癌検出用マーカー
US20050277137A1 (en) * 2003-08-15 2005-12-15 University Of Pittsburgh Diagnostic multimarker serological profiling
US20060106119A1 (en) 2004-01-12 2006-05-18 Chang-Jie Guo Novel integration for CO and H2 recovery in gas to liquid processes
JP2008514205A (ja) * 2004-09-29 2008-05-08 財団法人実験動物中央研究所 Nogマウスを用いた高転移性細胞株の樹立
US8383357B2 (en) 2005-03-16 2013-02-26 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
WO2006110585A2 (en) 2005-04-07 2006-10-19 Novartis Vaccines And Diagnostics Inc. Cancer-related genes (prlr)
JP2008535857A (ja) 2005-04-07 2008-09-04 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド 癌の診断、検出および処置におけるcacna1e
JP2007051880A (ja) 2005-08-15 2007-03-01 Tokyo Univ Of Science 膵臓癌の検出方法、膵臓癌の診断キット
WO2007107774A2 (en) * 2006-03-22 2007-09-27 Cartela R & D Ab Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer
KR100819122B1 (ko) * 2006-09-30 2008-04-04 남명진 췌장암 진단용 키트
US9353415B2 (en) 2006-12-19 2016-05-31 Thomson Reuters (Scientific) Llc Methods for functional analysis of high-throughput experimental data and gene groups identified therefrom
ES2442919T3 (es) 2007-03-27 2014-02-14 Immunovia Ab Firma/marcadores de proteínas para la detección de adenocarcinoma
GB0723179D0 (en) * 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
CA2736124A1 (en) * 2008-09-03 2010-03-11 The Johns Hopkins University Pathways underlying pancreatic tumorigenesis and an hereditary pancreatic cancer gene
WO2010102195A2 (en) 2009-03-06 2010-09-10 The Johns Hopkins University Annexin a11 and associated genes as biomarkers for cancer
CN101880707A (zh) * 2009-05-05 2010-11-10 中国人民解放军第二军医大学 microRNA-21在鉴别胰腺癌中的应用
CN101613748A (zh) * 2009-06-09 2009-12-30 中国人民解放军第二军医大学 一种检测胰腺癌血清标志物的方法
SG168431A1 (en) * 2009-07-23 2011-02-28 Univ Singapore Cancer biomarker and the use thereof
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
GB201319878D0 (en) 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof

Similar Documents

Publication Publication Date Title
JP2014508298A5 (enExample)
BR112012019542A2 (pt) "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit"
JP2013521763A5 (enExample)
JP2011524537A5 (enExample)
JP2014525584A5 (enExample)
Jabaudon et al. Soluble forms and ligands of the receptor for advanced glycation end-products in patients with acute respiratory distress syndrome: an observational prospective study
JP2009521215A5 (enExample)
Brodska et al. Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis
JP2015505370A5 (enExample)
Blokzijl et al. Protein biomarker validation via proximity ligation assays
JO3812B1 (ar) أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1)
JP2012509477A5 (enExample)
JP2013533469A5 (enExample)
WO2012006632A3 (en) Lung cancer biomarkers and uses thereof
JP2010538282A5 (enExample)
JP2016503301A5 (enExample)
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
JP2013539867A5 (enExample)
WO2012120288A3 (en) Method, array and use for determining the presence of pancreatic cancer.
WO2013062515A3 (en) Lung cancer biomarkers and uses thereof
Savvateeva et al. Biomarkers of Community‐Acquired Pneumonia: A Key to Disease Diagnosis and Management
JP2012501318A5 (enExample)
WO2009121024A3 (en) Methods for detecting antibodies
Jalali et al. Aptamer based diagnosis of crimean-congo hemorrhagic fever from clinical specimens
JP2018528441A5 (enExample)